Login

Switch On Your HIV Smarts.

Can a Two-Drug Treatment Regimen Keep HIV Under Control?

Can a Two-Drug Treatment Regimen Keep HIV Under Control?

, by Liz Highleyman

HIV therapy with two drugs, instead of three, kept 90% of people undetectable in a small proof-of-concept study. Read More

San Francisco HIV experts: What did you learn at AIDS 2016?

San Francisco HIV experts: What did you learn at AIDS 2016?

, by Emily Newman

BETA asked HIV doctors, providers and researchers to give us a taste of what they learned and what was exciting at this year’s biggest HIV and AIDS conference. Read More

Nurse-led PrEP clinic in San Francisco shares model of success at AIDS 2016

Nurse-led PrEP clinic in San Francisco shares model of success at AIDS 2016

, by Emily Newman

Who should provide PrEP to people who need it? In San Francisco, a community-based organization has found that a nurse-led clinic for gay men works well. Read More

AIDS 2016: Undetectable with long-acting, user-friendly injectable HIV medications

AIDS 2016: Undetectable with long-acting, user-friendly injectable HIV medications

, by Liz Highleyman

More than 90% of people receiving a long-acting injection of cabotegravir and rilpivirine maintained an undetectable HIV viral load. Read More

HIV Treatment Plus PrEP Virtually Eliminates HIV Transmission

HIV Treatment Plus PrEP Virtually Eliminates HIV Transmission

, by Liz Highleyman

HIV risk was reduced by 95% for people in serodiscordant relationships with PrEP and TasP, results of the Partners PrEP study show. Read More